348Curated trials
Enterprise Evidence Report · NR-REPORT-V2.0
China
Neuroscience Intelligence
China neuroscience evidence report: current clinical, research, institution and source-linked intelligence.
Evidence rank #4 of 50 · Data maturity A · Research score 51.6 · Data confidence 100.0 / 100 · Snapshot 2026-10-12 03:34 UTC.
113Recruiting trials
1,275Publications
518Institutions
Executive interpretation
China ranks #4 in the current NeuroRisk evidence-ranked market layer. This ranking summarizes indexed clinical, publication and institution evidence; it is not a probability of commercial success and not an investment recommendation.
Methodology status
Methodology NR-REPORT-V2.0. No synthetic ML confidence is presented as scientific probability. Counts and source links below are tied to the generation snapshot.
Methodology →Leading sponsors
Beijing Tiantan Hospital136 recruiting
Xijing Hospital123 recruiting
Merck Sharp & Dohme LLC125 recruiting
Shanghai Mental Health Center103 recruiting
Xuanwu Hospital, Beijing95 recruiting
Second Affiliated Hospital, Zhejiang University, School of Medicine83 recruiting
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine80 recruiting
Hoffmann-La Roche72 recruiting
Ruijin Hospital73 recruiting
University of Electronic Science and Technology of China62 recruiting
Disease activity
Stroke51trials
Parkinsons49trials
Alzheimers31trials
Epilepsy29trials
Autism23trials
Depression19trials
Adhd16trials
Other Neurology16trials
Schizophrenia10trials
Multiple Sclerosis10trials
Research institutions
Second Hospital of Hebei Medical UniversityOpenAlexlinked institution
Institute of ChemistryOpenAlexlinked institution
Shanxi Medical UniversityOpenAlexlinked institution
Hebei Medical UniversityOpenAlexlinked institution
First Hospital of Shanxi Medical UniversityOpenAlexlinked institution
Guangxi Medical UniversityOpenAlexlinked institution
Tangshan Gongren HospitalOpenAlexlinked institution
Jining First People's HospitalOpenAlexlinked institution
North China University of Science and TechnologyOpenAlexlinked institution
Xi’an Jiaotong-Liverpool UniversityOpenAlexlinked institution
Clinical evidence trail
NCT07830277Drug-Coated Balloon vs Aggressive Medical Management for High-Risk Symptomatic Intracranial Atherosclerotic StenosisNOT_YET_RECRUITING
NCT07801014The Impact of Dexmedetomidine Nasal Spray on Perioperative Anxiety in Neurosurgical PatientsNOT_YET_RECRUITING
NCT07790224Multi-Parameter Temporal Interference Stimulation in Patients With Epilepsy Undergoing SEEG MonitoringNOT_YET_RECRUITING
NCT07784088Implantable Wireless Brain-Computer Interface Systems in Patients With TetraplegiaRECRUITING
NCT07754942Inflammatory Markers and Prognosis After Cerebral Thrombectomy in Large Vessel OcclusionNOT_YET_RECRUITING
NCT07752784Evaluate the Concordance Between PET Imaging of [18F]-APN-1607 Injection and Postmortem Brain Tissue Tau Pathology in Individuals With HV and MCI or AD.RECRUITING
NCT07730762A Study of Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) for Insomnia During PregnancyACTIVE_NOT_RECRUITING
NCT07721688Different Frequency Temporal Interference Stimulation on Bilateral Subthalamic Nucleus for Parkinson's DiseaseRECRUITING
NCT07692022Social Cognition in Children and Adolescents With Autism Spectrum DisorderACTIVE_NOT_RECRUITING
NCT07679256Integrated Digital and Neurogenic Exosome Biomarkers for Early Diagnosis of Parkinson's Disease: Development and ApplicationRECRUITING
Research evidence trail
PUBMEDAn accessible digital single-molecule sensing platform for plasma P-tau217 quantification in Alzheimer's disease screening.2027-02-15
PUBMEDSimultaneous and ultrasensitive detection of Alzheimer's disease blood biomarkers using magnetic SERS-encoded tags-based LFIA assay.2027-02-01
PUBMEDA signal-locked clamped hybridization chain reaction nanoamplifier for rapid and highly sensitive analysis of Aβ42.2027-02-01
PUBMEDCoupled NIR-II fluorescence and mass spectrometry imaging of H2S-associated redox dysregulation in Parkinsonian models.2027-01-15
PUBMEDThe gut-liver-brain axis in alcohol use disorder: The emerging role of bile acid dysregulation.2027-01-05
PUBMEDMapping intrinsic neural timescale alterations in first-episode, drug-naïve adolescent-onset schizophrenia.2027-01-05
PUBMEDWhy the body matters in major depressive disorder: Neuroimaging findings of somatic symptoms and ongoing challenges.2027-01-05
PUBMEDEscitalopram and N-acetylcysteine alleviate major depressive disorder with cognitive impairment through YTHDC1/ATF4/CHOP-mediated pyroptosis.2027-01-05
PUBMEDMolecular Architecture of Temporal Variability Network Dysfunction in Bipolar Disorder.2027-01-01
PUBMEDEngineering functional vasculatures to reconstruct sympathetic-parasympathetic circuits for bladder function after spinal cord injury.2027-01-01
PUBMEDSerum sialic acid is independently associated with cerebrovascular atherosclerotic stenosis severity and total vascular burden: A retrospective cohort study.2027-01-01
World Bank context
Macro indicators are shown only where a timestamped World Bank source row exists. They are context, not NeuroRisk predictions.
Sources and provenance
ClinicalTrials.gov provides NCT evidence. PubMed/NCBI and OpenAlex provide research metadata. OpenAlex links institutions. World Bank indicators are included only when an explicit source row and year exist. NeuroRisk transformations add normalization, ranking and graph connections.
Limitations
Indexed corpus counts are not guaranteed exhaustive global totals. Scores are comparative decision-support signals. This report is not medical advice, regulatory advice, patent clearance, an investment recommendation or a guarantee of outcome.